Investors & Media

SEC Filing Details

Investor Relations Menu
Investor Home
News & Events
Press Releases Events & Presentations
Stock Information
Stock Quote & Chart Historic Price Lookup Investment Calculator Analyst Coverage
Financials & Filings
SEC Filings
Corporate Governance
Documents & Charters Management Team Board of Directors Scientific Advisory Board Committee Composition
Investor Resources
Investor FAQs Investor Contact Email Alerts
Contact

Carlo Tanzi, Ph.D.
Kendall Investor Relations
ctanzi@kendallir.com

Document Details

Form
DRS/A
Filing Date
Feb 14, 2020
Document Date
Feb 14, 2020
Form Description
Amendment to a previously filed DRS
Filing Group
Registration Statements
Company
Zentalis Pharmaceuticals
Issuer
ZENTALIS PHARMACEUTICALS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS